Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
5-α-Reductase inhibitor.
Furanolactone found in citrus fruits.
Azapirone; α1-adrenergic and 5-HT1A partial ag...
Inhibitor of TRK.
Dual kinase and GTPase inhibitor.
Mycotoxin contaminant found in cereal grains.
Cyclic hexapeptide isolated from Phomopsis lept...
May induce apoptosis in lymphoma cell lines.
p38 MAPK inhibitor.
Peptide, derivative of AT II, involved in vasoc...
Thienopyridine; P2Y12 antagonist.
EGFR inhibitor.
NS3/4A inhibitor
PI3K and HDAC inhibitor.
Alkaloid found in Corydalis and Stephania; D1/2...
Synephrine is an endogenous alkaloid.
Antioxidant shown to improve renal function.
Impurity of omeprazole
Purine derivative; CDK inhibitor.
Endogenous RF-amide peptide, involved in nocice...